Skip to content

Novavax NVAX Proceeds from the exercise of stock-based awards, net of tax withholding

Proceeds from the exercise of stock-based awards, net of tax withholding at other companies

Payoneer Global Inc. logo
Payoneer Global Inc.PAYO
-$2.54M+42.2%
AMP
Amphastar PharmaceuticalsAMPH
$686K-85.4%
Conagra Brands logo
Conagra BrandsCAG
$400K0.0%
City Holding Company logo
City Holding CompanyCHCO
$0-100%
Atlanta Braves Holdings, Inc. logo
Atlanta Braves Holdings, Inc.BATRA
$26.82M+3,850%
Eagle Bancorp logo
Eagle BancorpEGBN
$1.1M

Other financials

Income statement

See full
Revenue$139.5M-79.1%
Gross profit$108.8M-83.3%
Operating income-$15.4M-103%
Net income-$9.5M-102%
EPS (diluted)-$0.06-102%

Balance sheet

See full
Cash & equivalents$228.4M-13.3%
Total debt$295.1M+404%
Total equity-$144.8M-91.4%
Total assets$1.0B-19.3%

Cash flow

See full
Operating cash flow-$32.4M+82.5%
CapEx$1.3M-20.4%
Free cash flow-$33.7M+82.0%

Valuation

See full
Market cap$1.46B+41.0%
Enterprise value$1.53B+83.6%
P/S2.5×+1.6×

Profitability

See full
Gross margin85%-2.5pp
Operating margin-13.1%-45.9pp
Net margin-14.7%-52.9pp
FCF margin-58.9%-61.4pp

Returns & leverage

See full
Return on equity-238.6%
Debt / equity1.5×
Current ratio2.5×+0.4×

Where this comes from

Reported directly by Novavax in its filing.

Tagged under the XBRL concept nvax:ProceedsFromExerciseOfStockBasedAwardsNetOfTaxWithholding.

The official record: Novavax’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →

Ask your AI about Novavax's proceeds from the exercise of stock-based awards, net of tax withholding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Novavax's proceeds from the exercise of stock-based awards, net of tax withholding?
Novavax (NVAX) reported proceeds from the exercise of stock-based awards, net of tax withholding of -$1.2M in Q4 2025.
How has Novavax's proceeds from the exercise of stock-based awards, net of tax withholding changed year-over-year?
Novavax's proceeds from the exercise of stock-based awards, net of tax withholding decreased by 467.7% year-over-year, from $326.25K to -$1.2M.
What is the long-term trend for Novavax's proceeds from the exercise of stock-based awards, net of tax withholding?
Over 2 years (2023 to 2025), Novavax's proceeds from the exercise of stock-based awards, net of tax withholding has grown at a 449.3% compound annual growth rate (CAGR), from $159K to -$4.8M.
What does proceeds from the exercise of stock-based awards, net of tax withholding mean?
Measures the net cash received by the company from employees and directors exercising stock options or purchasing shares through equity incentive plans, adjusted for tax withholding obligations. This metric reflects the dilution impact and the cash-generating potential of employee compensation programs. It serves as a gauge for the alignment between employee incentives and shareholder interests.